In hepatocellular carcinoma, IGF2BP1 can bind and stabilize c-MYC and MKI67 mRNAs, increase the expression of c-MYC and MKI-67 proteins, which are effective regulators of cell proliferation and apoptosis, and thus participate in regulation of tumor progression (119). Here, MKI67 is linked to hepatocellular carcinoma.